BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 30, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Memantine: Phase IV data

Data from an exploratory, double-blind, European Phase IV trial in 195 patients with mild to moderate PDD or DLB showed that there was no significant difference between memantine and placebo in improving Alzheimer's disease cooperative study-clinical global impression of change rating (ADCS-CGIC) scores from baseline to week 24 (3.5 vs. 3.8, p=0.12). In...

Read the full 242 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >